Clinical Trial Update: Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the efficacy of oral vancomycin prophylaxis to prevent recurrent Clostridioides difficile infection. The study has completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• oral vancomycin (vancomycin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Recurrent Clostridium Difficile Infection, Clostridium Difficile Infection | Phase 2 | Status: COMPLETED | Results posted: 2025-05-25